Eton Pharmaceuticals, Inc. · NASDAQ:ETON
Krempa David sold 25,000 Eton Pharmaceuticals, Inc. shares (Form 4)
Traded Aug 24, 2026 · Filed Aug 24, 2026
On Aug 24, 2026, Krempa David (Chief Business Officer) sold 25,000 Eton Pharmaceuticals, Inc. shares at US$65.07 for US$1.63M, leaving 37,025 shares. Filed Aug 24, 2026 (Form 4).
- Sold
- 25,000 shares
- Price
- US$65.07
- Value
- US$1.63M
- Holding after
- 37,025 shares
- Trading plan
- No
- Role
- Chief Business Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | Common Stock | Option exercise | 25,000 | US$7.31 | 62,025 | Direct |
| Aug 24, 2026 | Common Stock | Sale | 25,000 | US$65.07 | 37,025 | Direct |
Source
Related
- Eton Pharmaceuticals, Inc.
- Krempa David
- Eton Pharmaceuticals, Inc. shareholders
- Form 4 · Krempa David · Oct 6, 2026
- Form 4 · Krempa David · Jul 13, 2026
- Form 4 · Krempa David · May 27, 2026
- Form 4/A · Maier Paul V · Aug 31, 2026
- Form 4 · Brynjelsen Sean · Aug 20, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4/A · Opaleye Management Inc. · Jul 17, 2026
- Form 4 · Brynjelsen Sean · Jul 14, 2026